Extended spectrum beta-lactamase urinary tract infections

被引：0
作者：
Aboumarzouk, Omar M. [1 ,2 ]
机构：
[1] Islam Univ Gaza, Coll Med, Acad Dept, Gaza, Palestine
[2] Wales Deanery, Dept Urol, Cardiff, S Glam, Wales
来源：
UROLOGY ANNALS | 2014年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：114 / 115
页数：2
相关论文
共 50 条
  • [31] Clinical and Economic Outcomes Associated with Urinary Tract Infections Caused by Extended Spectrum Beta-lactamase Producing Bacteria in a Tertiary Care Hospital
    Sozen, Hamdi
    Caylak, Selmin
    Cetinkaya, Mehmet
    Citil, Burak Ekrem
    Sahins, Cem
    Deliktas, Hasan
    Aksozek, Alper
    Kirli, Ismail
    STUDIES ON ETHNO-MEDICINE, 2015, 9 (02) : 173 - 179
  • [32] Comparative Study on Antibiotic Resistance Profile of Extended-Spectrum Beta-Lactamase and Non-Extended-Spectrum Beta-Lactamase Escherichia coli Infections among Pediatric Population with Community-Acquired Urinary Tract Infections in a Tertiary Care Centre.
    Nisha, K. V.
    Shenoy, Rathika D.
    Shetty, Veena
    Shenoy, Vijaya
    Shetty, Avinash
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2015, 3 (06) : 47 - 51
  • [33] Activity of Beta-Lactam Beta-Lactamase Inhibitor Combinations Against Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae in Urinary Isolates
    Afridi, Faisal Iqbal
    Farooqi, Badar Jahan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2012, 22 (06): : 358 - 362
  • [34] Prevalence and risk factors for extended spectrum beta-lactamase producing Escherichia coli in patients with urinary tract infection
    Matsumoto, Minori
    Tanaka, Kazushi
    Takechi, Yoshizumi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S262 - S262
  • [35] Prevalence and risk factors for extended spectrum beta-lactamase producing Escherichia coli in patients with urinary tract infection
    Matsumoto, M.
    Fukunaga, H.
    Tanaka, K.
    Takechi, Y.
    Yamada, Y.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 140 - 140
  • [36] Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection
    Cormican, M
    Morris, D
    Corbett-Feeeney, G
    Flynn, J
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (04) : 317 - 319
  • [37] Detection of extended-spectrum beta-lactamase production in Enterobacteriales from patients with suspected urinary tract infections, Tabora region, Rural Tanzania
    Nestor, David
    Malmvall, Bo-Eric
    Masonda, Yohana Paul
    Msafiri, John
    Sundqvist, Martin
    APMIS, 2018, 126 (08) : 700 - 702
  • [38] Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control
    Bouassida, Khaireddine
    Jaidane, Mehdi
    Bouallegue, Olfa
    Tlili, Ghassen
    Naija, Habiba
    Mosbah, Ali Tahar
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (3-4): : E87 - E93
  • [39] Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum beta-lactamase producing strains
    Yeganeh-Sefidan, Fatemeh
    Ghotaslou, Reza
    Akhi, Mohammad Taghi
    Sadeghi, Mohammad Reza
    Mohammadzadeh-Asl, Yalda
    Baghi, Hussein Bannazadeh
    IRANIAN JOURNAL OF MICROBIOLOGY, 2016, 8 (02) : 125 - 131
  • [40] EPIDEMIOLOGY OF URINARY TRACT INFECTIONS CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) PRODUCING PATHOGENS AT A TERTIARY CARE SWISS UNIVERSITY HOSPITAL
    Bonkat, Gernot
    Muller, Georg
    Rieken, Malte
    Frei, Reno
    Widmer, Andreas F.
    Feicke, Antje
    Wyler, Stephen
    Rentsch, Cyrill A.
    Ebinger-Mundorff, Nicole
    Subotic, Svetozar
    Gasser, Thomas C.
    Bachmann, Alexander
    JOURNAL OF UROLOGY, 2011, 185 (04) : E545 - E545
12345